BackAlbany Molecular Research Overview

Albany Molecular Research Other Current Assets

Albany Molecular Research's other current assets is $36M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$35.93M
11.54% YoYΔ $3.72M vs prior year quarter

Peer average / median

Loading

Albany Molecular Research Other Current Assets History

Loading

Albany Molecular Research vs. peers: Other Current Assets Comparison

Loading

Albany Molecular Research Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Albany Molecular Research (AMRI) FAQ

As of the most recent data (June 2017), AMRI shows a other current assets of $36M. That compares with $32M in the prior-year period — up 11.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMRI's other current assets is now $36M (was $32M) — a 11.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Albany Molecular Research is outperforming or lagging.

Tracking AMRI's other current assets over time shows whether Albany Molecular Research is scaling, shrinking, or reshaping that part of the business. The current reading is $36M That compares with $32M in the prior-year period — up 11.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Albany Molecular Research's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $36M) with ownership activity and broader fundamentals.